diagnosi
identif
virus
import
compon
diagnost
virolog
laboratori
although
variou
mode
diagnost
method
avail
dispos
vast
major
diseas
across
globe
remain
undiagnos
larg
due
overlap
undifferenti
set
symptom
across
myriad
set
rna
dna
viral
diseas
becom
critic
take
consider
sever
factor
viral
diagnosi
rang
type
qualiti
specimen
collect
time
specimen
collect
mode
transport
accuraci
specif
sensit
type
diagnost
method
use
chapter
broadli
emphas
variou
method
diagnost
virolog
rang
classic
method
diagnosi
recent
develop
molecular
method
detect
viru
virus
oblig
intracellular
parasit
detect
identif
imper
compon
clinic
viral
infecti
signifi
major
portion
public
health
perspect
thousand
death
annual
notwithstand
highli
contagi
infect
seriou
pandem
common
influenza
episod
clinic
diagnosi
viral
infect
often
reli
earli
detect
therefor
effectu
detect
virus
indispens
aid
avert
transmiss
initi
befit
therapi
scrutin
respons
treatment
lead
effect
diseas
control
manag
souf
viral
diagnosi
dynam
process
although
prophylaxi
better
cure
accur
diagnosi
viru
fundament
infect
equal
vital
gener
diagnost
test
categor
three
group
direct
detect
isol
viru
serolog
test
direct
examin
method
mere
faster
examin
directli
presenc
viru
particl
viru
antigen
viral
nucleic
acid
immunofluoresc
assay
extens
use
rapid
identif
viru
infect
detect
viru
antigen
virusspecif
antibodi
clinic
specimen
viral
diagnosi
crucial
revolut
render
access
make
potenti
standard
recent
develop
diagnost
method
serolog
essenti
compris
bulk
work
virolog
laboratori
serolog
diagnosi
identifi
increas
titer
antibodi
among
acut
convalesc
stage
infect
detect
immunoglobulin
igm
diagnosi
viral
infect
enhanc
notic
onset
highli
sensit
method
viz
enzymelink
immunosorb
assay
elisa
pcr
supersed
reason
nevertheless
last
year
techniqu
util
due
uniqu
natur
make
diagnosi
probabl
visual
viru
introduct
elisa
revolution
viral
diagnosi
simplifi
detect
shorten
time
torranc
jone
molecular
diagnost
tool
viral
diagnosi
trial
speedi
advanc
last
year
hayden
pers
revolution
diagnosi
infecti
diseas
particularli
viral
diseas
use
amplif
techniqu
viz
pcr
rtpcr
nasba
nucleic
acid
sequencebas
amplif
van
belkum
niester
detect
viru
genotyp
quantif
sever
advantag
high
reproduc
sensit
includ
broad
dynam
rang
ebner
et
al
ebner
et
al
sever
molecular
diagnost
techniqu
recent
swap
fulli
autom
devic
use
less
time
maneuv
smaller
volum
liquid
provid
quantifi
result
improv
accuraci
current
review
emphas
advanc
immunotechniqu
specif
characterist
diagnost
method
revolution
field
viral
diagnosi
clinic
decad
transmiss
electron
microscopi
tem
mere
imag
techniqu
permit
direct
imag
virus
attribut
nanoscal
resolut
classic
techniqu
owe
advantag
direct
visual
viru
amid
tem
contribut
breakthrough
dole
diagnost
tool
recogn
numer
viru
unswervingli
biolog
sampl
reason
modern
year
role
tem
diagnosi
anonym
infecti
agent
specif
viral
outbreak
transmiss
cluster
shift
regular
use
initi
screen
test
tem
also
consid
import
method
assess
viral
safeti
biopharmaceut
product
applic
tem
understand
unknown
virus
immin
risk
contamin
tem
undeni
function
document
subsist
virus
viruslik
particl
cell
product
deriv
roingeard
et
al
immunoassay
primarili
antibodyantigen
depend
assay
principl
work
immun
antigen
activ
infect
therefor
measur
igg
immunoglobulin
quantifi
antibodi
preferenti
use
diagnost
marker
antigen
antibodi
coat
conjug
label
like
metal
radioact
isotop
fluoresc
tag
respect
part
modern
research
immunotechniqu
diagnost
approach
chronic
hepat
c
infect
chc
detect
specif
antibodi
hcv
antihcv
indirect
test
assay
detect
quantifi
character
compon
hcv
viral
particl
viz
hcv
rna
core
antigen
direct
test
quantif
hcv
core
antigen
cag
onestep
procedur
indispens
henc
order
evalu
perform
cag
quantif
diagnos
chc
predispos
concomit
hiv
hbv
infect
crosssect
valid
assay
ie
hcv
ag
quantif
onestep
procedur
diagnos
chc
cameroon
design
abridg
diagnost
process
duchesn
et
al
pertin
note
multiplex
microspher
immunoassay
mia
recent
develop
possess
diagnost
power
incarcer
viral
envelop
protein
evok
strong
crossreact
antibodi
flavivirus
differenti
power
viral
nonstructur
protein
interestingli
serolog
assay
need
employ
rapid
clinic
diagnosi
zikv
andor
dengu
viru
infect
screen
immun
respons
vaccin
trial
wong
et
al
noteworthi
oral
fluid
noninvas
biospecimen
harbor
pathogenspecif
antibodi
reach
potenti
replac
bloodbas
test
protocol
therefor
salivabas
oral
fluid
immunoassay
develop
assess
past
recent
hepat
e
viru
hev
infect
noninvas
sampl
method
sensit
specif
assay
compar
serumbas
elisa
salivari
assay
could
improv
understand
ecolog
natur
histori
hev
pisan
et
al
diagnos
zikv
remain
great
challeng
detect
viral
rna
possibl
mere
day
onset
symptom
convers
novel
highthroughput
imagebas
fluoresc
neutral
method
identif
zikv
thoroughli
evalu
develop
report
higher
sensit
plaqu
reduct
neutral
test
prnt
macelisa
respect
test
might
employ
clinic
diagnosi
clinic
trial
confirm
seropreval
studi
zikv
infect
koishi
et
al
one
recent
studi
detect
serum
hev
antigen
ag
deem
sensit
promis
biomark
hev
antigen
diagnosi
hev
rna
acut
chronic
genotyp
strikingli
antigen
assay
recent
evalu
diagnos
hev
genotyp
higher
sensit
commerci
antihev
igm
hev
rna
elisa
test
zhang
et
al
nonetheless
recent
studi
respiratori
syncyti
viru
rsv
develop
luciferas
immunoprecipit
system
lip
assay
detect
igg
antibodi
human
rsv
gglycoprotein
moreov
human
rsv
gglycoprotein
also
act
biomark
natur
exposur
immun
rsv
gene
encod
nativ
mutat
g
mg
protein
subgroup
b
strain
clone
express
luciferasetag
protein
experi
separ
spot
antirsvg
specif
igg
antibodi
employ
highthroughput
luciferas
immunoprecipit
system
lipsg
pertin
note
rsv
monoclon
antibodi
polyclon
antisera
explicitli
bound
lipsg
andor
g
b
assay
crim
et
al
diagnosi
zikv
dengu
viru
denv
infect
viral
envelop
protein
nonstructur
protein
ns
develop
use
flaviviru
multiplex
microspher
immunoassay
mia
howev
mia
could
differenti
recent
past
infect
repres
key
diagnost
challeng
therefor
recent
report
immunoglobulin
g
igg
base
avid
assay
develop
diagnost
perform
accur
differenti
recent
zika
past
dengu
viru
infect
assay
found
use
patient
high
risk
zika
complic
viz
pregnant
women
monitor
immun
respons
vaccin
trial
furuya
et
al
consecut
develop
serolog
diagnosi
zikviga
zikvigg
avid
assay
evalu
character
zika
infect
want
viremia
assay
facilit
constru
low
avid
igg
iga
result
enhanc
serolog
diagnosi
zikv
amaro
et
al
anoth
studi
homolog
protein
divers
flavivirus
exhibit
high
degre
sequenc
uniqu
mainli
within
subgroup
led
preval
immunolog
crossreact
therefor
proport
deconvolut
complex
b
cell
respons
zikv
flaviviru
deliber
screen
microarray
chipbas
highresolut
serolog
analysi
prime
overlap
peptid
cover
whole
amino
acid
sequenc
zikv
genom
polyprotein
develop
addit
advent
assay
sever
infect
viz
dengu
yellow
fever
tickborn
enceph
west
nile
virus
shall
diagnos
hansen
et
al
enzym
extens
tool
diagnos
viru
variou
applic
like
enzym
immun
assay
elisa
enzym
immun
assay
differ
applic
like
fluoresc
polar
immun
assay
fpia
microparticl
immun
assay
meia
chemiluminesc
clia
enzym
immun
assay
work
antigenantibodi
interact
conjug
tag
like
fluoresc
tag
chemiluminesc
tag
complement
substrat
like
polar
light
fluoresc
substrat
part
advanc
immunotechniqu
ultrasensit
colorimetr
assay
call
magnet
nano
e
zymelink
immunosorb
assay
maglisa
develop
wherein
silicashel
magnet
nanobead
magnb
gold
nanoparticl
pool
monitor
influenza
viru
femtogram
per
millilit
concentr
oh
et
al
sensit
specif
detect
crimeancongo
hemorrhag
fever
viru
cchfv
develop
employ
specif
igm
igg
antibodi
human
sera
use
recombin
cchfv
nucleoprotein
antigen
igg
immun
complex
ic
elisa
test
emmerich
et
al
recent
truncat
form
hev
niv
hendra
nipah
viru
g
protein
well
fulllength
niv
nucleocapsid
n
protein
use
detect
hendra
nipah
viru
specif
antibodi
pig
recombin
protein
express
divers
express
system
indirect
elisa
develop
detect
fischer
et
al
rapid
diagnost
platform
colorimetr
differenti
detect
denv
chikv
viral
infect
recent
develop
possibl
alter
clinic
diagnosi
acut
febril
ill
resourcelimit
set
platform
princip
facilit
consist
accur
multiplex
detect
chikungunya
dengu
igmigg
antibodi
human
clinic
sampl
within
short
stint
immunofluoresc
extens
use
speedi
detect
viral
infect
clinic
start
earli
use
diagnosi
viru
antigen
virusspecif
iggigaigm
antibodi
clinic
specimen
techniqu
fluoresceinlabel
antibodi
stain
specimen
contain
specif
viru
antigen
use
uv
illumin
part
modern
research
immunotechniqu
new
recombin
rabi
viru
express
green
fluoresc
protein
rrvgfp
rapid
simpler
less
expens
detect
quantif
viru
neutral
antibodi
blood
sera
techniqu
simplifi
multistep
rapid
fluoresc
focu
inhibit
test
rffit
procedur
purg
immunostain
step
qin
et
al
b
nucleic
acid
dna
rna
amplif
assay
convent
known
polymeras
chain
reaction
pcr
distinct
pcr
exist
base
type
nucleic
acid
inform
known
propo
sequenc
genom
immunodetect
rou
sarcoma
viru
rsv
one
signific
caus
agent
respiratori
tract
infect
children
relat
high
morbid
mortal
howev
littl
known
refer
effect
respiratori
viral
infect
revers
transcript
recombinas
polymeras
amplif
assay
rtrpa
nucleic
acid
probe
base
novel
isotherm
amplif
techniqu
wide
employ
detect
human
rsv
result
exemplifi
concurr
rate
rtrpa
assay
qrtpcr
assay
clinic
sampl
demonstr
rtrpa
assay
hold
better
diagnost
present
clinic
sampl
remot
rural
area
develop
countri
xi
et
al
use
quantit
pcr
qpcr
common
respiratori
virus
two
gene
recogn
extrem
upregul
viral
infect
notabl
rnaseq
viru
detect
achiev
sensit
compar
qpcrbase
screen
asthmat
children
consequ
drive
immun
cell
airway
infiltr
cellular
remodel
alter
asthmogen
gene
express
wesolowskaandersen
et
al
nevertheless
part
latest
advanc
immunotechniqu
isotherm
revers
transcript
recombinas
polymeras
amplif
rtrpa
synthet
rna
ebola
viru
employ
paper
microfluid
devic
develop
initi
later
base
rna
detect
multiplex
analysi
ebola
viru
diagnost
optim
demonstr
high
sensit
addit
ninespot
multilay
devic
achiev
parallel
detect
three
distinct
rna
sequenc
open
rout
direct
detect
multipl
viral
pathogen
magro
et
al
rabi
viru
rabv
one
signific
global
zoonot
pathogen
two
sensit
realtim
quantit
rtpcr
assay
develop
valid
largespectrum
detect
rabv
focu
african
isol
primer
probe
set
target
highli
conserv
region
nucleoprotein
n
polymeras
l
gene
effect
detect
high
sensit
assay
effect
function
gener
research
use
diagnost
process
epizoot
surveil
fay
et
al
howev
recent
time
fluoresc
revers
transcript
loopmedi
isotherm
amplif
rtlamp
employ
quench
probe
detect
middl
east
respiratori
syndrom
coronaviru
develop
addit
detect
efficaci
qprobe
rtlamp
compar
rtpcr
assay
azhar
furthermor
assay
well
use
authorit
diagnost
tool
rapid
detect
surveil
merscov
infect
shirato
et
al
consecut
assist
detect
zikv
infect
distinguish
infect
denv
chikv
trioplex
realtim
rtpcr
assay
recent
develop
howev
perform
trioplex
realtim
rtpcr
assay
particularli
employ
detect
zikv
denv
chikv
virus
simultan
test
one
specimen
type
patient
afford
superior
diagnost
sensit
techniqu
santiago
et
al
situ
hybrid
rnaish
assay
recent
develop
detect
viral
hemorrhag
septicemia
viru
vhsv
oie
list
piscin
rhabdoviru
infect
fish
cell
fathead
minnow
fhm
model
cell
line
two
antisens
rna
probe
target
fragment
n
g
gene
amplifi
rtpcr
employ
vhsvspecif
primer
trail
transcript
reaction
presenc
digoxigenin
dutp
compet
local
vhsv
mrna
infect
cell
diagnost
sensit
rnaish
assay
better
immunocytochemistri
qrtpcr
tcid
qadiri
et
al
develop
evalu
new
onestep
realtim
rtpcr
assay
develop
detect
latest
influenza
virus
compet
caus
human
infect
sensit
onestep
realtim
rtpcr
assay
gener
determin
use
vitro
transcrib
rna
devoid
crossreact
rna
subtyp
influenza
virus
viral
respiratori
pathogen
nonspecif
reaction
saito
et
al
current
trend
mass
spectrometri
ms
benchmark
qualit
quantit
diagnosi
virus
clinic
clinic
laboratori
maldi
matrixassist
laser
desorpt
ioniz
es
electrospray
ioniz
method
frequent
use
allow
ioniz
analyt
consider
amount
combin
rtpcresim
abl
detect
viral
pathogen
acut
viral
respiratori
infect
influenza
virus
usual
virus
undetect
regular
test
method
well
provid
rapid
detail
data
type
subtyp
viru
short
period
deyd
et
al
chen
et
al
yet
anoth
studi
report
nearinfrar
spectroscopi
nir
rapid
reagentfre
costeffect
tool
use
detect
zikv
noninvas
head
thorac
intact
aed
aegypti
mosquito
high
predict
accuraci
rel
quantit
rtqpcr
reaction
perhap
techniqu
could
extend
upon
identifi
probabl
arboviru
hotspot
guid
spatial
priorit
vector
control
fernand
et
al
recent
develop
surfac
plasma
reson
spr
spectroscopi
develop
valuabl
optic
biosensor
potenti
method
diagnosi
dengu
viru
eprotein
also
identif
antibodi
denv
antigen
diagnosi
limit
sensit
select
spr
sens
denv
antigen
amazingli
high
techniqu
introduc
novel
multilay
thin
film
futur
research
spr
sens
applic
omar
fen
mirna
conserv
small
noncod
rna
nucleotid
regul
posttranscript
modif
mirna
transcrib
rna
polymeras
ii
premirna
process
dicer
transport
cytoplasm
risc
cytoplasm
process
premirna
matur
mirna
regul
posttranscript
activ
part
advanc
immunotechniqu
exosom
microrna
recent
studi
potenti
diagnost
marker
variou
malign
includ
hepatocellular
carcinoma
hcc
serum
exosom
microrna
combin
alphafetoprotein
diagnost
marker
hepatocellular
carcinoma
anoth
studi
synthet
mirnabas
approach
develop
express
neutral
antibodi
directli
lung
via
aerosol
prevent
human
rsv
influenza
infect
engin
mrnaexpress
antibodi
prevent
rsv
infect
noteworthi
express
membraneanchor
broadli
neutral
antibodi
lung
could
potenti
promis
pulmonari
prophylaxi
approach
tiwari
et
al
recent
studi
endogen
microrna
mirna
evolutionarili
conserv
presenc
biolog
fluid
signifi
regulatori
role
circul
mirna
pathogenesi
immun
respons
viral
infect
hand
noninvas
diagnost
approach
use
biomark
current
play
central
role
earli
diagnosi
viral
infect
given
fact
recent
report
depict
numer
circul
microrna
biomark
viz
influenza
arbovirus
hepat
infect
diagnost
function
respect
ojha
et
al
tabl
nextgener
sequenc
ng
one
noteworthi
achiev
record
current
era
ahead
genom
sequenc
known
organ
permit
breakthrough
new
virus
depend
unknown
human
diseas
track
viral
outbreak
pandem
influenza
comprehend
emerg
transmiss
profil
viral
divers
nextgener
sequenc
sampl
provid
exact
precis
estim
time
sinc
infect
consequ
infect
regenc
also
crucial
surveil
understand
viral
pathogenesi
ngsderiv
averag
pairwis
divers
exhibit
higher
sensit
specif
compar
fraction
ambigu
nucleotid
carlisl
et
al
noteworthi
metagenom
nextgener
sequenc
assay
mng
panpathogen
detect
effect
test
patient
acut
ill
sever
viral
etiolog
connect
custom
bioinformat
pipelin
surpi
recent
design
quickli
analyz
mng
data
gener
autom
summari
detect
pathogen
provid
graphic
user
interfac
evalu
interpret
result
miller
et
al
panpathogen
metagenom
sequenc
assay
slev
st
loui
enceph
viru
infect
csf
cerebrospin
fluid
unbias
approach
infecti
diseas
test
although
sever
challeng
still
remain
relat
test
avail
interpret
valid
report
howev
recent
metagenom
nextgener
sequenc
employ
diagnos
fatal
case
meningoenceph
caus
slev
chiu
et
al
anoth
studi
metagenom
viral
sequenc
potenti
diagnost
test
influenza
also
provid
insight
transmiss
drug
resist
evolut
simultan
detect
virus
pertin
oxford
nanopor
technolog
employ
metagenom
sequenc
respiratori
sampl
technolog
oper
high
sensit
compar
current
diagnost
standard
techniqu
certainli
approach
may
show
great
promis
nanopor
platform
use
diagnosi
genet
analysi
influenza
clinic
respiratori
virus
lewandowski
et
al
tabl
recent
past
design
diagnost
therapeut
platform
base
aptam
technolog
undoubtedli
potenti
approach
viral
infect
nevertheless
oligonucleotid
aptam
potenti
altern
monoclon
antibodi
base
detect
could
aim
protein
infect
cell
compon
viral
particl
deem
probabl
novel
diagnost
molecul
viral
hepat
noteworthi
aptam
molecul
could
favor
substitut
monoclon
antibodi
near
futur
mirian
et
al
sensit
select
electrochem
immunosensor
labelfre
zikv
protein
detect
recent
develop
employ
function
interdigit
microelectrod
gold
ideau
array
zikv
immunesens
chip
integr
miniatur
potentiostat
mp
interfac
smart
phone
rapid
zikvinfect
detect
obligatori
earli
stage
diagnost
pointofcar
applic
kaushik
et
al
howev
costeffect
portabl
grapheneen
biosensor
detect
zikv
highli
specif
immobil
monoclon
antibodi
recent
develop
field
effect
biosens
feb
monoclon
antibodi
coval
link
graphen
enabl
realtim
quantit
detect
nativ
zikv
antigen
assay
firstofitskind
grapheneen
zika
biosensor
make
ideal
candid
develop
medic
diagnost
test
afsahi
et
al
accur
time
diagnosi
new
reassort
avian
influenza
crucial
control
diseas
outbreak
view
simpl
strategi
rapid
sensit
detect
viru
achiev
employ
intensitymodul
surfac
plasmon
reson
imspr
biosensor
techniqu
integr
newli
gener
monoclon
antibodi
novel
antibodi
demonstr
noteworthi
specif
identifi
viru
compar
homemad
targetcaptur
elisa
qrtpcr
rapid
influenza
diagnost
test
ridt
high
sensit
chang
et
al
recent
studi
sandwichtyp
electrochemiluminesc
ecl
immunosensor
develop
ultrasensit
determin
hbv
surfac
antigen
primari
antibodi
hb
ab
immobil
surfac
carboxylmodifi
magnet
nanoparticl
mnp
pamam
dendrim
mani
amin
function
group
employ
carrier
immobil
cdte
cd
quantum
dot
qd
secondari
antibodi
ab
amplifi
ecl
signal
qd
consider
improv
sensit
strikingli
ecl
sensor
design
base
signal
amplif
dendrimerquantum
dot
structur
babamiri
et
al
anoth
studi
hemagglutinin
ha
glycoprotein
present
surfac
influenza
subtyp
viru
viru
bind
human
cell
sialic
acid
membran
upper
respiratori
tract
earli
detect
swine
flu
infect
human
impedimetr
hemagglutinin
genebas
biosensor
develop
immobil
aminolabel
singlestrand
dna
probe
onto
cystein
modifi
gold
surfac
screen
print
electrod
earli
rapid
detect
swine
flu
human
mohan
et
al
microfluid
techniqu
permit
research
viral
measur
fusion
kinet
viral
infect
screen
viral
respons
neutral
molecul
besid
microfluid
platform
also
signifi
promis
innov
clinic
tool
applic
clinic
diagnost
includ
drug
screen
microfluid
specif
emphas
array
techniqu
concern
precis
control
manipul
fluid
within
microscop
channel
whitesid
moder
clearcut
percept
underpin
rang
biolog
research
techniqu
flow
cytometr
dna
analys
enzym
immunoassay
duncomb
et
al
recent
studi
investig
use
integr
microfluid
system
diagnost
util
aptam
iav
viral
detect
tsang
et
al
studi
remark
two
recent
studi
infect
murin
noroviru
mnv
also
util
dropletbas
microfluid
platform
test
conveni
neutral
antibodi
explor
impact
viruscel
interact
fischer
et
al
sinc
viral
infect
complex
highli
dynam
process
appreci
affect
physic
chemic
environ
studi
infect
biolog
prefer
occur
microfluid
system
use
crisprca
system
rnabas
gene
therapi
current
rais
numer
potenti
therapeut
applic
latest
uniqu
rna
target
gene
therapi
success
appli
observ
staphylococcu
pneumonia
crispr
rna
sequenc
repeat
target
foreign
dna
cleavag
bind
pam
flank
sequenc
mediat
endonucleas
call
ca
guid
rna
grna
respons
doubl
strand
break
host
foreign
dna
silenc
gene
express
nonhomolog
end
join
nhej
differ
kind
mediat
differ
ca
protein
notabl
like
class
type
ii
grna
complement
ca
protein
system
eventu
class
ii
type
v
complement
crispr
code
crrna
act
guid
rna
complement
type
v
ca
protein
complex
crisperca
system
identifi
makarova
et
al
applic
crisprca
viral
diagnost
make
breakthrough
increas
specif
type
v
use
detect
viral
dna
design
specif
viral
dna
ssdna
tag
report
fluorophor
quencher
end
cleavag
activ
viral
dna
confer
cleavag
ssdna
result
flourophor
report
cleavag
ssdna
emit
fluoresc
detect
quencher
amplifi
recombinas
polymeras
pcr
techniqu
character
detectr
method
like
sherlock
gootenberg
et
al
work
consient
base
system
tool
special
appli
zika
viru
diagnosi
tabl
novel
array
crispr
screen
aptli
base
plasmid
librari
express
singleguid
rna
sgrna
disrupt
gene
encod
kinas
protein
relat
endocytosi
golgiloc
protein
individu
use
sgrna
crispr
screen
uncov
host
factor
indispens
infect
coxsackieviru
compris
human
pathogen
caus
divers
diseas
techniqu
sensit
compar
array
screen
base
sirnamedi
knockdown
lenti
viralbas
crispr
screenbas
sgrna
plasmid
pool
employ
potenti
diagnost
tool
hpv
target
viral
diseas
autom
poc
system
ebv
detect
rnaguid
rna
endonucleas
employ
collater
rna
degrad
subsequ
activ
recent
develop
qin
colleagu
follow
autom
microfluid
mix
hybrid
nonspecif
cleavag
product
allow
quantifi
customintegr
fluoromet
base
diagnost
method
rapid
amplificationfre
simpl
sensit
thu
establish
key
technolog
toward
use
poc
diagnost
platform
qin
et
al
b
prologu
new
class
nanoscal
materi
manifold
except
properti
function
spark
seri
breakthrough
applic
biomed
diagnost
applic
pertin
note
recent
advanc
nanoparticlebas
later
flow
immunoassay
pointofcar
diagnost
tool
infecti
agent
diseas
recent
develop
detect
infecti
viral
agent
later
flow
immunoassay
lfia
technolog
paperbas
pointofcar
strip
biosensor
design
detect
specif
analyt
virusinfect
sampl
banerje
jaiswal
aunpbas
detect
techniqu
report
variou
group
clinic
relev
virus
uniqu
focu
appli
type
bioaunp
hybrid
structur
viru
detect
target
assay
modal
format
recent
develop
draz
shafie
recent
develop
diagnost
viral
techniqu
redesign
field
clinic
virolog
could
contribut
reduct
incid
seriou
infecti
viral
diseas
foremost
advantag
molecular
techniqu
higher
sensit
specif
match
diagnost
method
viz
serolog
assay
cultur
method
well
rapid
possibl
autom
nevertheless
technolog
capabl
alon
inadequ
sustain
health
promot
polici
boost
conscious
propo
signific
earli
detect
infecti
viral
diseas
outbreak
spread
conclus
good
qualiti
diagnosi
cost
develop
countri
afford
regular
practic
far
delay
execut
newfangl
method
develop
world
diseas
endem
area
convers
anticip
assert
effort
may
persist
toward
develop
new
highqual
test
inexpens
lowincom
countri
would
consider
reinforc
diseas
control
strategi
